Diarrhea

2'-Fucosyllactose (2'-FL) is the most abundant human milk oligosaccharide and functions as a prebiotic with evidence linking it to reduced diarrhea risk. Research has shown human milk alpha-1,2-linked fucosylated oligosaccharides (including 2'-FL) decrease risk of diarrhea from E. coli stable toxin in breastfed infants. Animal and in vitro studies show 2'-FL inhibits E. coli adherence and reduces EPEC-related diarrhea when combined with probiotics.

Activated charcoal is used as an over-the-counter antidiarrheal in many countries. A randomized, double-blind study on 100 adults with nonspecific diarrhea showed significant reductions in stool frequency and duration versus placebo. It works by adsorbing bacterial toxins and pathogens in the gut lumen. Evidence is mixed and NCCIH notes it lacks solid proof for traveler's diarrhea specifically.

Diarrhea is among the primary traditional indications of Atractylodes macrocephala, and it features prominently in TCM formulas for infantile and adult functional diarrhea. Multiple animal studies and some clinical TCM formula trials support its use for functional and inflammation-related diarrhea.

Bacillus clausii has the strongest and most replicated clinical evidence base for treating and preventing diarrhea. A systematic review and meta-analysis of six RCTs in nearly 1,300 children found B. clausii combined with ORS significantly reduced diarrhea duration (mean difference −9.12 h) and hospitalization. Two RCTs in adults also demonstrated significant reduction in antibiotic-associated diarrhea, including during H. pylori eradication therapy. Typical dosing studied is 2–4 billion CFU/day in children and up to 6 billion CFU/day in adults.

Multiple randomized controlled trials show B. coagulans reduces stool frequency and severity of diarrhea in IBS-D patients. A double-blind RCT with B. coagulans MTCC 5856 (2×10⁹ CFU/day, 90 days) significantly reduced diarrhea frequency vs. placebo. B. coagulans LMG S-31876 at 2 billion CFU/day over 8 weeks also produced significant decline in diarrhea symptoms. Pediatric acute diarrhea has also been studied with positive outcomes.

Green banana is one of the best-documented natural interventions for persistent childhood diarrhea. RCTs in Bangladeshi children showed green banana or pectin reduced stool output and duration of diarrhea. Green banana resistant starch also reduces intestinal permeability and fluid loss, and improves bowel consistency in adults.

Barberry (Berberis vulgaris) contains berberine and has traditional and scientific evidence for treating infectious diarrhea. It is explicitly listed in complementary medicine references as a berberine-containing plant that may help treat infectious diarrhea. The evidence base derives from berberine's clinical trial record (multiple RCTs) in diarrhea.

Germinated barley foodstuff (GBF) has been shown to attenuate diarrhea in ulcerative colitis through its high water-holding fiber fraction that modulates stool water content. Clinical trials in UC patients document reduction in nocturnal diarrhea and bloody stools following GBF supplementation.

Belleric myrobalan has documented antidiarrheal properties supported by preclinical mechanistic studies and in vitro antimicrobial data against gastrointestinal pathogens. The fruit's tannins exert astringent action on the intestinal mucosa, and its anticholinergic and calcium antagonist effects (demonstrated in pharmacological studies) reduce intestinal hypermotility. Traditional use across Ayurveda, Unani, and traditional Chinese medicine for diarrhea is extensive.

Berberine is one of the best-studied natural antidiarrheal agents with multiple RCTs. A 1987 RCT in 165 adults showed 400 mg berberine sulfate significantly reduced stool volume in ETEC diarrhea. A 2015 RCT in 196 IBS-D patients found 400 mg/day berberine hydrochloride significantly reduced diarrhea frequency, abdominal pain, and urgency versus placebo. A 2020 systematic review of 38 RCTs (3948 participants) confirmed efficacy in both children and adults.

Bifidobacterium species (as a genus) are extensively documented in Cochrane reviews and meta-analyses for prevention and treatment of diarrhea. A Cochrane review of 33 RCTs (6352 children) showed Bifidobacterium spp. among the probiotic strains that reduced antibiotic-associated diarrhea incidence from 19% to 8%. A meta-analysis of 63 trials of acute infectious diarrhea also documented benefit from Bifidobacterium-containing interventions.

Multiple randomized controlled trials demonstrate that B. animalis subsp. lactis strains (BB-12, BLa80, HN019) reduce the duration and incidence of diarrhea in children and adults. A 2024 RCT in children aged 0–3 years found BLa80 at 5×10⁹ CFU/day significantly shortened diarrhea duration versus placebo. BB-12 has also been shown to reduce antibiotic-associated diarrhea and is documented in over 130 human clinical studies. The mechanism involves pathogen exclusion, maintenance of tight junction integrity, and immune modulation.

Bifidobacterium bifidum has been documented alongside L. acidophilus and S. boulardii in a 12-study meta-analysis showing statistically significant effects on reducing and preventing traveler's diarrhea (P<0.001). It is included in Cochrane reviews of probiotic interventions for diarrhea in children.

Bifidobacterium breve has been studied for diarrhea in pediatric populations and is included in meta-analyses and Cochrane reviews of probiotic interventions for antibiotic-associated and acute infectious diarrhea. It is one of the predominant Bifidobacterium species in infant gut microbiota and has been evaluated in infant and childhood diarrhea.

Bifidobacterium infantis is recognized for its role in gut microbiota modulation in infants and has been studied in the context of reducing diarrhea and gastrointestinal disturbances. It is among the Bifidobacterium species included in broader probiotic reviews demonstrating benefit for diarrhea in children.

Bifidobacterium lactis has clinical evidence for reducing acute infectious diarrhea duration in children. A Bayesian network meta-analysis of 84 RCTs (13,443 children) found it reduced diarrhea duration by approximately 0.98 days versus placebo (moderate GRADE certainty). It is also documented in Cochrane reviews of antibiotic-associated diarrhea prevention in children.

Bifidobacterium longum is supported by evidence within the broader Bifidobacterium literature for antibiotic-associated and acute infectious diarrhea. It is included in Cochrane reviews and meta-analyses of probiotic interventions demonstrating reduced AAD incidence from 19% to 8% in children.

Bile acid malabsorption (BAM) is a well-established cause of chronic watery diarrhea. When bile salts escape ileal reabsorption and enter the colon in excess, they stimulate colonic secretion and accelerate motility, producing urgent, watery stools. BAM is confirmed clinically by SeHCAT scintigraphy or serum 7α-hydroxy-4-cholesten-3-one (C4) measurement. Up to one-third of patients diagnosed with IBS-D have underlying BAM as a contributing mechanism.

Multiple preclinical studies have documented antidiarrheal activity for A. scholaris bark extracts. In castor-oil-induced diarrhea models in mice, aqueous and alcoholic bark extracts significantly reduced diarrheal episodes and stool weight, comparing favorably with the Ayurvedic standard Kutajarishta and loperamide. The mechanism involves spasmolytic activity via calcium channel blockade.

Deficiency of pancreatic lipase and amylase leads to fat and starch malabsorption, producing steatorrheal diarrhea. Pancreatic enzyme preparations, including bovine-derived pancreatin, have been shown in RCTs to reduce fecal fat, stool weight, and stool frequency in EPI-related diarrhea. A meta-analysis of 17 RCTs confirmed reduced fecal fat excretion and stool weight versus placebo. Clinical improvements in stool frequency and consistency have been documented in both CP-related and IBS-related EPI subsets.

Butyric acid is used clinically for the treatment and prevention of diarrhea, including antimicrobial-associated and dysbiosis-related forms. It stabilizes the intestinal barrier and modulates microbial composition. Evidence derives from clinical use, case series, and mechanistic research.

A randomized controlled trial published in Food & Function (2023) demonstrated that C. cassia water extract improved diarrhea symptoms by modifying the intestinal microbiome environment. Cassia bark is also one of the most documented traditional remedies for diarrhea across TCM and Ayurvedic medicine.

Animal model studies demonstrate that A. aspera extracts significantly inhibit castor oil-induced diarrhea and reduce intestinal fluid accumulation. Multiple solvent extracts have been tested, with ethyl acetate extract showing highest activity.

Chamomile (Matricaria recutita) has traditional and limited clinical evidence for diarrhea. A large RCT (255 children, double-blind) found that a product combining apple pectin and chamomile significantly improved acute diarrhea symptoms. Chamomile has anti-inflammatory, antispasmodic, and antimicrobial properties attributed to apigenin and alpha-bisabolol.

Chen Pi has a documented history of traditional use for diarrhea across thousands of years in TCM, and is listed in the Chinese Pharmacopoeia for GI conditions including diarrhea. Mechanistic studies show its flavonoids reduce intestinal inflammation and modulate motility.

Pectin has documented clinical evidence for reducing diarrhea, particularly in children. A randomized clinical trial in 57 male infants showed pectin and green banana significantly reduced diarrhea. Pectin's gel-forming, water-absorbing properties normalize stool consistency; it is a classical component of anti-diarrheal preparations.

Bovine colostrum has been studied in 22 clinical trials (1427 patients) for gastrointestinal diseases. A 2024 systematic review found that diarrhea frequency decreased in 15 of 20 evaluated interventional arms, and stool frequency was consistently reduced across seven studies. Evidence is rated as limited and mixed overall, but bovine colostrum demonstrates a signal of benefit for reducing diarrhea frequency.

Commiphora myrrh (in combination with chamomile and coffee charcoal as Myrrhinil-Intest®) is approved in Germany and supported by a double-blind RCT for gastrointestinal disorders including diarrhea associated with IBD. Myrrh alone has traditional use as an astringent antidiarrheal.

Diarrhea is one of the most frequently documented gastrointestinal symptoms in histamine intolerance due to DAO deficiency. Clinical trials of DAO supplementation show significant improvement in diarrhea and loose stool in deficient patients. Serum DAO levels are inversely correlated with gastrointestinal symptom severity.

Dioscoreae Rhizoma (dried yam) is listed in the Chinese Pharmacopoeia for treatment of long-term diarrhea. Preclinical evidence from a 2023 animal study shows it improves chronic diarrhea by modulating gut microbiota. Traditional use across TCM is extensively documented.

Diarrhea is among the GI symptoms measured in clinical trials of gluten-digesting enzyme mixtures containing DPPIV-active peptidases in NCGS patients. Gluten and casein sensitivity can manifest as diarrhea when immunogenic peptides reach the intestinal mucosa incompletely digested. The 2018 NCGS crossover RCT (PMC6143542) included diarrhea in its symptom questionnaire and reported overall significant symptom improvement with the enzyme mixture. Digestive enzyme therapy reviews also document evidence for enzyme blends reducing post-prandial diarrhea in IBS-like contexts.

C. speciosa has documented traditional use against dysentery and diarrhea in TCM for centuries, and laboratory research has begun to identify the active constituents responsible. Triterpenoids including oleanolic, ursolic, and betulinic acids were identified as active agents against E. coli heat-labile enterotoxin (LT)-induced diarrhea. The plant's astringent tannins also contribute to anti-diarrheal activity.

FOS acts as a soluble, osmotically active fiber that draws water into the colon and increases bacterial biomass, softening stools and improving bowel regularity. A 2024 systematic review and meta-analysis of 17 RCTs found FOS significantly increased bowel movement frequency and improved stool consistency, including in infants with constipation. At high doses (>20 g/day), FOS itself can cause osmotic diarrhea as an adverse effect.

Poria cocos polysaccharides have been studied for antibiotic-associated diarrhea (AAD) in preclinical models, showing restoration of gut microbiota homeostasis, increased tight junction protein ZO-1 expression, and improved intestinal mucosal barrier integrity. The Chinese Pharmacopoeia lists loose stools and diarrhea among Fu Ling's primary indications.

Diarrhea has been measured as an outcome in RCTs of alpha-galactosidase. In a randomized double-blind placebo-controlled study in healthy volunteers given a high-bean meal, breath hydrogen excretion and symptoms including diarrhea were tracked for 8 hours; the 1200 GalU dose produced significant reductions in total symptom scores. A pilot study combining alpha- and beta-galactosidase in subjects intolerant to complex carbohydrates also reported significant reduction in diarrhea. Evidence is limited by small sample sizes.

Ginger (Zingiber officinale) has preclinical and clinical evidence for reducing diarrhea-predominant IBS symptoms. Animal studies show ginger significantly reduced defecation frequency, fecal water content, and colonic inflammation in IBS-D models, with effects equivalent to rifaximin. Human studies suggest ginger helps reduce pain and stool changes in IBS-D. It is listed in complementary medicine databases as a proposed treatment for diarrhea.

Glucomannan's gel-forming and water-absorbing properties can add bulk to loose stools and slow transit, potentially reducing diarrhea severity. Konjac glucomannan hydrolysates have been studied in patients with IBD-related diarrhea, and IBS trials have reported improvements in both constipation and diarrhea subtypes.

Holarrhena antidysenterica is its eponymous indication, with the plant's bark and seeds used for centuries to treat diarrhea and amoebic dysentery. The principal alkaloid conessine demonstrates direct antidysenteric and anti-amoebic action against Entamoeba histolytica. Preclinical studies confirm antidiarrheal activity via dual mechanisms on gut motility. Multiple pharmacological reviews in peer-reviewed literature confirm this as the most robustly evidenced use.

Serum-derived bovine IgG (SBI) has been evaluated in multiple clinical studies for managing chronic diarrhea across several conditions. A pilot study in 30 IBS-D patients showed statistically significant reductions in loose stools, abdominal pain, and urgency at 5–10 g/day. SBI is also registered as a medical food for diarrhea management in IBS-D and HIV-associated enteropathy.

Indian bael (Aegle marmelos) has robust preclinical and mechanistic evidence as an antidiarrheal agent. Decoctions of unripe fruit pulp have been shown to inhibit bacterial adherence to gut epithelium and neutralize enterotoxins from pathogens including E. coli and rotavirus. This validates centuries of Ayurvedic use of bael as a first-line antidiarrheal remedy.

H. indicus has well-documented antidiarrheal properties supported by both in vitro and in vivo preclinical studies. The plant is listed in pharmacological reviews as possessing anti-diarrheal activity, and traditional Ayurvedic use in diarrhea and dysentery is extensively recorded. A root paste with pepper is a traditional preparation used specifically for diarrhea.

Jujube fruit extract has demonstrated antidiarrheal activity in castor oil– and E. coli–induced mouse models at doses of 400–1200 mg/kg. The astringent properties of jujube have been recognized in traditional medicine across South and Southeast Asia for diarrhea management. Evidence remains preclinical.

L-Alanyl-L-Glutamine (AG) has been investigated as an oral rehydration component for infectious and secretory diarrhea. As a stable, highly soluble dipeptide, it enhances water and electrolyte intestinal absorption. A randomized, double-blind, placebo-controlled trial in HIV/AIDS patients demonstrated that 24 g/day AG for 10 days improved intestinal absorption in those with recent diarrhea. Animal models show AG outperforms free glutamine and glucose in reversing cholera-toxin-induced secretory diarrhea.

L-glutamine is the primary fuel for enterocytes and supports tight junction integrity, reducing intestinal permeability that underlies secretory diarrhea. Clinical use in diarrhea-predominant IBS and infectious diarrhea is supported by trials showing reduced stool frequency and improved gut barrier markers.

In lactose-intolerant individuals, insufficient lactase allows undigested lactose to reach the colon, where bacterial fermentation produces osmotic load and short-chain fatty acids that draw water into the colon, causing diarrhea. Exogenous lactase supplementation has been shown in RCTs and systematic reviews to significantly reduce lactose-induced diarrhea. A single dose of approximately 9,900 FCC units reduced breath hydrogen and symptoms including diarrhea compared to placebo.

The Lactobacillus genus broadly is among the most evidence-supported interventions for multiple forms of diarrhea. Cochrane reviews, meta-analyses, and international guidelines (ESPGHAN/ESPID) support Lactobacillus strains for reducing the duration of acute infectious diarrhea, preventing antibiotic-associated diarrhea, and reducing traveler's diarrhea in adults and children.

Lactobacillus acidophilus has been documented in meta-analyses as one of the strains with statistically significant effects on reducing and preventing traveler's diarrhea, alongside Saccharomyces boulardii and Bifidobacterium bifidum (P<0.001, 12-study meta-analysis). It is also included in Cochrane reviews on antibiotic-associated diarrhea in children.

L. bulgaricus, typically combined with other lactic acid bacteria, has clinical evidence supporting reduction of antibiotic-associated diarrhea (AAD) and travelers' diarrhea. A 2022 systematic review and meta-analysis specifically addressed the L. acidophilus/L. bulgaricus combination for diarrhea treatment. A landmark RCT (BMJ, 2007) demonstrated that a drink containing L. bulgaricus, L. casei, and S. thermophilus significantly cut AAD and C. difficile-associated diarrhea rates. Evidence is strongest for AAD prevention in adults over 50.

L. casei (notably strain GG/LGG) has been studied in multiple RCTs for reducing the duration and severity of acute infectious diarrhea, particularly rotavirus-associated diarrhea in children. Evidence also exists for reducing antibiotic-associated diarrhea (AAD) risk, though results are strain- and dose-dependent. Mechanistically, the organism restores lactic-acid-producing flora, competes with pathogens, and enhances mucosal IgA. Benefits are most robust for viral gastroenteritis in developed-country settings.

L. gasseri BNR17 was evaluated in a double-blind, placebo-controlled RCT in patients with diarrhea-predominant IBS, significantly improving diarrhea symptoms and quality of life. Colon transit time was also corrected in a significantly greater proportion of BNR17 recipients versus placebo, and beneficial microbiota changes were documented.

Multiple L. paracasei strains have clinical evidence for diarrhea management. L. paracasei B21060 in a synbiotic formulation showed efficacy in acute childhood diarrhea, and ST11 ameliorated non-rotavirus diarrhea in children. L. paracasei CNCM I-1572 modulated gut microbiota and increased fecal butyrate in IBS, although primary symptom endpoints were not significantly improved.

Lactobacillus plantarum has been studied for diarrhea in the context of IBS-D and antibiotic-associated diarrhea. It is included in Cochrane reviews of probiotic interventions for diarrhea. RCTs have demonstrated significant reductions in IBS-related bowel disturbances including diarrhea-predominant symptoms.

Multiple RCTs and meta-analyses support Lactobacillus reuteri for reducing the duration of acute infectious diarrhea in children. A Bayesian network meta-analysis of 84 RCTs (13,443 children) found L. reuteri reduced diarrhea duration by MD=−0.84 day versus placebo and significantly reduced the risk of diarrhea lasting ≥2 days (OR=0.23), with moderate-certainty GRADE evidence.

Lactobacillus rhamnosus (including strain GG) is consistently supported by Cochrane reviews and meta-analyses for reducing diarrhea duration and preventing antibiotic-associated diarrhea in children and adults. A Cochrane review (33 RCTs, 6352 children) identified L. rhamnosus at 5–40 billion CFU/day as one of the most appropriate strains for preventing antibiotic-associated diarrhea.

L. salivarius has demonstrated reductions in diarrhea rate in preclinical models and shows mechanistic activity relevant to infectious diarrhea through intestinal barrier support and pathogen inhibition. Human evidence is indirect, stemming from its capacity to inhibit enteropathogens such as E. coli O157:H7 and to maintain intestinal barrier integrity. Evidence in humans remains limited compared to other probiotic species.

Preclinical studies demonstrate that L. lactis supplementation modulates intestinal immunity, reduces pathogen colonization, and normalizes gut microbiota composition in diarrhea models. In weaning piglet studies, L. lactis improved growth, regulated the GABAergic system, and modulated intestinal immune gene expression. Human evidence is indirect but supported by its role in restoring barrier integrity in inflammatory diarrhea contexts.

Bovine lactoferrin has been evaluated in multiple RCTs for infectious diarrhea in infants and young children, with positive findings for reducing prevalence, duration, and severity. A large double-blind RCT in 555 children demonstrated significant benefit. Results for antibiotic-associated diarrhea were not supportive in a separate pediatric trial.

Lipase deficiency from exocrine pancreatic insufficiency causes steatorrhea — oily, malodorous, loose stools — by preventing adequate fat hydrolysis in the small intestine. Supplemental lipase (via PERT) reduces steatorrhea and associated diarrhea in this population. The evidence is mechanistically robust and confirmed by multiple RCTs.

Medium-chain triglycerides (MCT) have shown promise as a treatment for HIV-associated diarrhea in preliminary double-blind studies. A double-blind clinical study found MCT-containing elemental diets improved gastrointestinal tolerance including diarrhea in HIV-infected people. MCT is listed in complementary medicine databases as a proposed treatment for diarrhea.

The licensed German herbal product Myrrhinil-Intest (myrrh, chamomile, coffee charcoal) is approved for treatment of diarrhea and has demonstrated efficacy in managing acute diarrhea in IBS in clinical settings. T-cadinol from myrrh inhibits cholera toxin–induced intestinal hypersecretion in animal models.

C. rotundus is one of its best-documented uses pharmacologically. Methanol and aqueous rhizome extracts at 250–500 mg/kg significantly reduced castor oil-induced diarrhea frequency in rat models. Tannins and volatile oils provide astringent and spasmolytic actions. It is also a primary traditional Ayurvedic use.

Isolated berberine from Berberis species, including Oregon grape, has been shown in double-blind clinical trials to effectively treat diarrhea caused by E. coli and other enteropathogens. Berberine inhibits bacterial adherence to intestinal epithelial cells and slows intestinal transit. PeaceHealth and broader herbalism monographs cite this as one of Oregon grape's best-supported uses.

Rice bran from Oryza sativa has a documented role in reducing diarrhea and enteric pathogen burden, supported by a published randomized controlled trial in weaning infants. The soluble fiber and prebiotic content of rice bran are the primary proposed mechanisms.

Excess bile acids reaching the colon stimulate colonic secretion and accelerated motility, causing bile acid diarrhea (BAD). Ox bile supplementation at pharmacological doses can worsen or provoke diarrhea in susceptible individuals; conversely, in bile-deficiency states such as short bowel syndrome, ox bile has been shown to resolve steatorrhea-driven diarrhea. The relationship is therefore bidirectional and context-dependent.

P. foetida has documented antidiarrheal activity in preclinical models. Ethanol extract significantly delayed onset of diarrhea and reduced purging index in castor oil and magnesium sulphate-induced models in mice. The mechanism is attributed to inhibition of intestinal motility. Traditional use for diarrhea and dysentery across South and Southeast Asia is well-documented.

Pectin is a soluble dietary fiber with evidence for diarrhea management, particularly in combination with chamomile. A large RCT (255 children, 6 months to 6 years) found apple pectin combined with chamomile significantly improved symptoms of acute diarrhea. Pectin is also listed as a proposed treatment for diarrhea in complementary medicine databases.

Peppermint oil reduces IBS-related diarrhea (IBS-D) through its established antispasmodic action on intestinal smooth muscle. The 2024 Japanese phase 3 trial confirmed efficacy across IBS-D subtypes, with 85.1% patient-reported improvement at 4 weeks. A 2019 meta-analysis of RCTs supports peppermint oil for global IBS symptom relief including diarrhea and abdominal pain.

P. amurense bark (Cortex Phellodendri) has documented use as an antidiarrheal agent in both TCM and Kampo medicine for centuries, and berberine—its primary alkaloid—is an established over-the-counter drug in China for bacterial diarrhea. Berberine's antimicrobial mechanism against diarrhea-causing pathogens (cholera, dysentery, staph) is well documented. Chinese studies on P. amurense bark confirm broad-spectrum antibiotic effects against diarrhea-causing organisms.

P. integerrima galls are used in India as 'kakad shringi' specifically for infantile diarrhea in Ayurvedic practice. A 2021 ACS Omega study (PMID 34179606) tested gall extracts and isolated flavonoids in castor-oil-induced diarrhea in mice, with the ethyl acetate fraction providing 100% protection at 400 mg/kg and two isolated flavonoids also achieving 100% protection. Molecular docking suggested mu- and delta-opioid receptor interactions as the mechanism.

Psyllium (Plantago ovata husk) shows documented clinical benefit in diarrhea, including both acute and chronic forms. Its gel-forming properties normalize stool consistency by absorbing excess water. Clinical trial evidence and gastroenterology society endorsements support this use.

Plantago psyllium (P. ovata) husk has documented clinical efficacy for both acute and chronic diarrhea, including diarrhea caused by enteral feeding. As a bulking agent, the gel-forming fiber absorbs excess luminal fluid and slows transit. P. major leaves with tannin content also show traditional antidiarrheal use with astringent preclinical support.

Potentilla (tormentil/Potentilla erecta) has been evaluated in two clinical studies for diarrhea. A randomized double-blind trial (40 children with rotavirus diarrhea) found tormentil root extract reduced diarrhea duration from 5 to 3 days (P<0.0001). A second study found it approximately as effective as loperamide for nonspecific diarrhea in adults. European herbal guidance recognizes it for symptomatic treatment of mild diarrhea.

Preclinical studies (in rodent models) show that Zanthoxylum bark and fruit extracts significantly reduce the severity and frequency of diarrhea. A PMC systematic review (Zhang et al., 2017) confirms regulatory effects on the gastrointestinal system. Traditional use across multiple cultures also documents prickly ash for diarrhea. However, no human clinical trials exist.

Psyllium (from Plantago ovata husk) is a soluble dietary fiber that acts as a bulk-forming agent, absorbing water in the colon to help normalize stool consistency. It is recognized in complementary medicine references as a treatment for diarrhea, and has been studied in IBS-D to firm loose stools and reduce diarrhea frequency.

Rhubarb root displays a documented bidirectional effect: its tannin fraction produces antidiarrheal activity while its anthraquinones produce laxative effects. Processed (charcoal or cooked) forms are used clinically to treat diarrhea in TCM. Preclinical studies confirmed that rhubarb tannins extract (RTE) significantly reduces fecal water content and inhibits aquaporin expression in diarrhea models.

Saccharomyces boulardii is among the most evidence-supported probiotics for diarrhea. Cochrane reviews and multiple meta-analyses confirm it reduces duration and incidence of antibiotic-associated diarrhea, traveler's diarrhea, and acute infectious diarrhea in children and adults. One network meta-analysis (84 RCTs, 13,443 children) found it reduced diarrhea duration by approximately 1.25 days vs. placebo (moderate certainty).

In TCM, Poria cocos sclerotium has long been used to treat spleen deficiency diarrhea. Preclinical studies show that its polysaccharides ameliorate antibiotic-associated diarrhea by restoring gut microbiota balance and reinforcing intestinal tight junction proteins.

S. baicalensis has documented anti-diarrheal effects through multiple mechanisms: baicalin inhibits COX-2/PGE2 (reducing intestinal inflammation), and wogonin directly inhibits colonic smooth muscle motility via a non-inflammatory mechanism. Preclinical data support use for diarrhea-predominant IBS and chemotherapy-induced diarrhea. TCM use for diarrhea spans 2,000 years.

Antidiarrheal activity is one of the documented pharmacological activities of A. muricata, supported by in vitro and in vivo preclinical studies. Traditional use of the fruit and bark as an astringent for diarrhea and dysentery is also well-recorded across multiple regions.

Clinical and preclinical evidence supports S. thermophilus in reducing antibiotic-associated diarrhea (AAD) and acute infectious diarrhea. The strain restores microbial balance, upregulates mucosal barrier proteins, and modulates pro-inflammatory cytokines. Studies in children show meaningful reductions in diarrhea duration and severity.

Sucrase deficiency is a well-documented cause of chronic osmotic diarrhea. When the sucrase enzyme is absent or reduced, undigested sucrose accumulates in the small intestinal lumen, producing watery hyperosmolar diarrhea through osmotic effects and subsequent fermentation by colonic bacteria. Sacrosidase enzyme replacement therapy has been clinically shown to significantly reduce or eliminate diarrhea in sucrase-deficient patients.

A. calamus has traditional use across multiple cultures for diarrhea and dysentery, with a pharmacological basis established via calcium channel blockade antispasmodic mechanisms. A 2006 Phytotherapy Research study confirmed antidiarrhoeal and antispasmodic activity in animal gut preparations.

Antidiarrheal activity of Swertia chirayita extracts has been demonstrated in preclinical pharmacological models. The plant is also traditionally used across South Asia for diarrhea and dysentery. Peer-reviewed reviews confirm antidiarrheal as a validated pharmacological property.

Aqueous and ethanolic stem bark extracts of T. cordifolia demonstrated dose-dependent antidiarrheal activity in castor oil- and magnesium sulfate-induced diarrhea rat models, reducing total stool count, wet stools, and onset time. This pharmacological evidence aligns with its traditional Ayurvedic use for dysentery and diarrhea.

Tributyrin has been studied in animal models of inflammatory diarrhea, where it improved colonic butyrate levels, restored SCFA transporter expression, and reduced intestinal inflammation. In antibiotic-treated mice, tributyrin supplementation alleviated antibiotic-induced diarrhea and intestinal damage. No robust human RCTs on diarrhea specifically exist, but preclinical evidence is consistent.

Vitamin A supplementation has been shown in multiple clinical trials to reduce morbidity and mortality from diarrheal disease, particularly in deficient children. The WHO recommends vitamin A supplementation in populations with deficiency partly on this basis. The mechanism involves vitamin A's role in sustaining intestinal mucosal barrier integrity.

Saccharomyces boulardii (a subspecies/variant of S. cerevisiae) has strong clinical evidence for the prevention and treatment of antibiotic-associated diarrhea, traveler's diarrhea, and acute infectious diarrhea. A systematic review and meta-analysis of 27 randomized controlled trials found it significantly efficacious and safe in 84% of treatment arms. Standard dose is >10^9 organisms/day.

Berberine from Yellow Root has well-documented clinical efficacy against acute infectious diarrhea, confirmed by multiple clinical trials. Yellow Root itself has been used traditionally for diarrhea and infectious intestinal distress. Berberine is widely used as an OTC antidiarrheal in China.

Multiple clinical studies show oral zeolite clinoptilolite reduces diarrhea symptoms. A 2022 randomized, double-blind, placebo-controlled trial (RCT) found G-PUR® improved IBS-D symptoms over 12 weeks. A 2025 observational study in 100 patients with drug-refractory chronic diarrhea reported improvements in stool consistency and abdominal pain. A non-interventional study in 204 IBS patients also documented clinically meaningful symptom reduction.

Zinc supplementation is recommended by WHO for acute diarrhea management in children, supported by multiple systematic reviews and meta-analyses. A systematic review of 38 RCTs commissioned by WHO found zinc supplementation reduced diarrhea duration by approximately 13.27 hours and increased recovery rate (RR=1.07, moderate certainty). For persistent diarrhea, recovery RR was 1.75.

Agrimony (Agrimonia eupatoria) has a well-documented history in European herbal medicine as a traditional remedy for diarrhea, attributed to its astringent tannin content. Scientific evidence is largely limited to in vitro and animal studies; few clinical trials have evaluated it for diarrhea directly. Complementary medicine sources list it as a traditional diarrhea remedy.

Diarrhea is one of the primary traditional indications of ajwain across Ayurvedic, Unani, and traditional Persian medicine. Antispasmodic, antimicrobial, and astringent properties are proposed as mechanisms. Calcium channel-blocking antispasmodic effects documented in preclinical research support the traditional use.

Oral ingestion of alkanet root for diarrhea is a documented traditional use spanning centuries across Mediterranean, European, and South Asian herbal medicine systems. The astringent properties from tannins and the root's vulnerary action are the proposed rationale. No controlled human clinical trials have evaluated this indication.

Allspice has a well-documented traditional use for diarrhea across Caribbean, Central American, and Ayurvedic herbal traditions. Its anti-diarrheal action is attributed to tannins providing astringency and eugenol's mild antimicrobial effects on enteric pathogens. No human clinical trials have been conducted.

A. galanga is used in traditional Chinese medicine and Ayurveda for diarrhea, dysentery, and gastric cold conditions. Pharmacological studies have demonstrated anti-diarrhea effects in animal models. The dried rhizome has been widely used for centuries for this indication.

Amaranth species have a well-documented tradition of use for diarrhea and dysentery across multiple cultures including Ayurvedic, African, and Asian folk medicine. Astringent properties of the plant are proposed as the mechanism. WebMD/RxList specifically lists diarrhea as a traditional use of amaranth. Formal human clinical trials for this indication are absent.

Andrographis has well-documented traditional use for diarrhea and dysentery across Ayurveda, Traditional Chinese Medicine, and Southeast Asian traditional medicine. It is described in TCM for 'toxic-heat type diarrhea' and has been used historically for dysentery. Modern preclinical data supports antimicrobial and anti-inflammatory actions that may underlie this traditional use.

Antidiarrheal use of annatto seeds (as astringents) and leaf/bark infusions for dysentery and diarrhea is broadly documented in the ethnobotany of Central and South America. Seeds are mildly astringent and have been used for gastrointestinal complaints including diarrhea and dysentery. No human clinical trials exist.

Treating diarrhea and dysentery is perhaps the most widely documented traditional use of baobab across Africa. Fruit pulp applied externally with buttermilk, oral preparations of fruit pulp, and leaf decoctions have all been used for this purpose across multiple countries. The soluble fiber content (mucilage) provides a plausible mechanism by absorbing excess intestinal fluid. One study compared a baobab solution to WHO oral rehydration solution in children with acute diarrhea, finding the baobab solution provided additional nutritional advantages though the WHO solution was slightly superior for rehydration.

Basil is documented in Ayurveda, TCM, and African traditional medicine for treatment of diarrhea. The fruit and leaves are used as decoctions or teas. Antimicrobial activity against enteric pathogens provides a plausible mechanism, but clinical trial evidence is absent.

Bayberry has a well-documented traditional use as an anti-diarrheal agent, rooted in both Native American and early colonial herbal practice. The root bark's tannins exert an astringent effect on mucous membranes, while the flavonoid myricitrin has demonstrated antimicrobial activity in laboratory studies. No controlled human clinical trials have confirmed efficacy for diarrhea specifically.

Decoctions and preparations of Piper betle leaves are used in traditional Asian medicine systems for diarrhea, attributed to the leaf's documented astringent, antimicrobial, and anti-motility properties. No controlled human clinical trials have been conducted.

Bilberry (Vaccinium myrtillus) has traditional use in European medicine for diarrhea, attributed to its high tannin content and astringent properties. NIH/LiverTox notes that in traditional medicine, bilberry was used to treat diarrhea and gastrointestinal complaints. Scientific clinical evidence for bilberry specifically for diarrhea is limited.

Black cumin is listed in traditional Unani and Islamic medicine as a remedy for diarrhoea and gastrointestinal disturbances. PMC gastrointestinal reviews document anti-motility, antispasmodic, and anti-infective properties in experimental models relevant to diarrhoea, though dedicated clinical trials are lacking.

Black pepper is documented in Ayurvedic, Unani, and traditional Chinese medicine as an antidiarrheal agent with antispasmodic properties. Piperine's antidiarrheal and antispasmodic pharmacological activities are listed in pharmacological reviews, supported by animal data.

The British Herbal Pharmacopoeia lists black spruce as helpful for diarrhea. This is a documented pharmacopoeia-level traditional use. No clinical studies have investigated this indication specifically.

Black tea has a long-standing traditional use for symptomatic relief of diarrhea, attributed to its high tannin content, which exerts astringent effects on the gastrointestinal mucosa. This use is documented across Asian, European, and African traditional medicine systems. Human clinical trial evidence is limited.

The astringent tannins in black walnut hull and leaves are the basis for its traditional antidiarrheal use. Native Americans used black walnut leaves for diarrhea. Tannins from similar plants have established antidiarrheal mechanisms, though black walnut–specific clinical studies are absent.

Blackberry root bark, leaves, and fruit have been used as antidiarrheal remedies since antiquity, documented by Dioscorides and in European and Native American folk medicine. The German Commission E and modern herbal references attribute the effect to high tannin content, which exerts an astringent action on the intestinal mucosa. Multiple Indigenous North American tribes used blackberry decoctions specifically for diarrhea.

Blessed thistle contains tannins that are traditionally credited with astringent action on the gastrointestinal mucosa, potentially reducing diarrheal symptoms. A mild infusion is described in traditional sources as astringent and soothing to the gut. There are no clinical trials specifically evaluating blessed thistle for diarrhea.

Ayurvedic texts list Boswellia (Shallaki) as indicated for diarrhea (Atisara) and dysentery. Traditional preparations used bark decoction or gum resin internally. No rigorous human RCT has evaluated Boswellia specifically for acute diarrhea as an isolated endpoint.

Orobanche species have documented traditional use for infantile diarrhoea and bowel disorders across Asian medicinal traditions and among North American indigenous peoples. The plant's astringent properties have historically been cited as the pharmacological rationale.

Cardamom has traditional use for diarrhea across Ayurvedic, South Asian, and traditional Sudanese medicine. Its antimicrobial properties against intestinal pathogens and proposed antispasmodic effects provide a plausible rationale. Laboratory studies suggest digestive support; direct human clinical trial evidence for diarrhea specifically is not available.

Cayenne has traditional documentation for use in diarrhea and gastrointestinal distress. URMC Rochester's herbal database notes cayenne may act as a digestive tonic. High doses of cayenne can paradoxically worsen diarrhea due to intestinal irritation. No clinical RCTs confirm anti-diarrheal efficacy.

Cinnamon bark and oil have documented traditional use for diarrhea across multiple pharmacopeial and ethnomedicinal systems, including Ayurvedic, Chinese, and European traditions. The Drugs.com monograph confirms this traditional indication. Human clinical evidence specifically for diarrhea as a primary endpoint is limited, with most supporting data from antimicrobial and gut microbiota studies.

Clove and eugenol have traditional use in Ayurvedic and Chinese medicine for diarrhea and gastrointestinal spasm. Eugenol has documented antispasmodic and antimicrobial properties relevant to infectious and spasmodic diarrhea, though controlled human trials are lacking.

TCM pharmacopeias and classical texts consistently list 'strengthening the spleen to prevent diarrhea' as a primary indication of coix seed, particularly for spleen deficiency diarrhea and loose stools related to dampness. This is a canonical TCM application documented across multiple authoritative herbal references.

Coptis chinensis (Huanglian) has been used in Traditional Chinese Medicine for thousands of years to treat diarrhea, dysentery, and gastrointestinal infections. Its primary active compound, berberine, has substantial clinical evidence for diarrhea (see berberine entry). TCM clinical applications for diarrhea are long-established, and modern reviews link its effects to berberine-mediated antisecretory and antimicrobial activity.

Cumin has been used in traditional medicine across South Asia, the Middle East, and Iran specifically to treat diarrhea. Classical herbal monographs and ethnobotanical surveys consistently cite this use. Clinical evidence specific to diarrhea is absent, though in vitro antimicrobial activity against enteric pathogens provides indirect support.

Dog Rose hips have a documented traditional use for managing diarrhea, attributed to their tannin-mediated astringency and mucilaginous properties that soothe and protect intestinal mucosa. Historical herbal records including Culpeper and German folk medicine consistently note this use.

American dogwood (Cornus florida) bark has a well-documented traditional use for chronic diarrhea, used by Native Americans, colonial physicians, and Civil War soldiers. Its astringent tannin content provides a plausible mechanism. No clinical trials exist, and WebMD/RxList classify the evidence as insufficient.

Fennel has traditional use as an antidiarrheal agent across multiple ethnomedicinal systems, attributable to its antimicrobial and antispasmodic properties. Preclinical data support plausible mechanisms, but dedicated human clinical trials for diarrhea are not available.

In traditional medicine systems, asafoetida is used for both constipation and diarrhea-predominant gastrointestinal complaints. Its antispasmodic and antimicrobial properties underpin its use for loose stools and gut dysbiosis. Small IBS clinical studies include both diarrhea and constipation phenotypes.

Garlic has a centuries-long tradition of use for diarrhea across multiple cultures, including Arabian herbal medicine, Chinese medicine, and Indian traditional practice. Modern pharmacological research supports antimicrobial properties of allicin against enteropathogens, providing a plausible biological basis for traditional use. Robust human clinical trials specifically for diarrhea treatment are lacking.

Traditional Chinese Medicine (from ~2000 BC) used garlic specifically for diarrhea and parasite infections. Garlic's antimicrobial properties (allicin) provide biological plausibility by targeting enteric pathogens. No modern human clinical trial has specifically evaluated garlic for diarrhea as a primary endpoint.

Gentiana species, particularly Gentiana scabra, have long been used in traditional Chinese and European medicine for gastrointestinal ailments including diarrhea. The PMC 2025 review of Gentianaceae confirms this traditional indication. No controlled human trials specifically for diarrhea have been published.

Gentian root has a documented traditional use in European herbal medicine for diarrhea, recorded in multiple historical and modern herbal references including PeaceHealth/TraceGains and RxList. The EMA's historical-use documentation lists diarrhea among traditional indications. No controlled clinical trials have been conducted to verify efficacy for this indication.

Geranium has documented traditional use for diarrhea and dysentery across multiple herbal traditions including African, European, and South African systems. The astringent tannin content provides a plausible mechanism. No clinical trials have been identified.

Goldenrod has traditional use for diarrhea documented in North American folk medicine and historical European herbalism. Astringent tannins reduce intestinal secretion and peristalsis, providing a pharmacological rationale. The A.D.A.M. database and traditional phytotherapy texts record this use. No clinical evidence exists.

Goldenseal (Hydrastis canadensis) contains berberine and is traditionally used in North American herbal medicine for infectious diarrhea. However, NCCIH states there is insufficient rigorous clinical evidence to determine its efficacy, and no high-quality studies have been published specifically on goldenseal for diarrhea. Its traditional use for diarrhea is attributed to its berberine content.

Amla is listed in traditional Ayurvedic and Unani medicine for diarrhea management. WebMD's NLM monograph notes this use. The astringent tannins in amla are mechanistically plausible as antidiarrheal agents, but clinical trial evidence is lacking.

Green chiretta has extensive traditional use for diarrhea, dysentery, and enteritis across Ayurveda, TCM, and Southeast Asian medicine. It was historically used in bacillary dysentery and is described as a treatment for intestinal infections and digestive upset. Modern preclinical data show gut antimicrobial and anti-inflammatory properties supporting this use.

Guarana's use against diarrhea is among its oldest documented traditional applications, stemming from its high tannin content, which exhibits astringent properties capable of reducing intestinal secretion. Indigenous groups across the Amazon basin and in Peru have used guarana for chronic diarrhea and dysentery. No dedicated human clinical trials have been conducted.

Diarrhea is one of the most consistently cited traditional uses of H. spicatum across multiple ethnobotanical surveys and systematic reviews, including Rawat et al. (2018, J Pharm Pharmacol). The rhizome is used in folk medicine throughout South Asia as an anti-diarrheal. Preclinical pharmacological confirmation of anti-diarrheal activity is limited in the indexed literature.

Honey has a long history of traditional use for diarrhea in Ayurvedic, Islamic, and Greek medicine, attributed to its antibacterial properties against intestinal pathogens. While in vitro evidence demonstrates antimicrobial activity against bacteria relevant to infectious diarrhea, robust human clinical trial evidence specifically for honey as a diarrhea treatment is lacking.

In TCM, honeysuckle has been used for 'heat-toxin blood dysentery' — a category that encompasses infectious diarrhea — for over 1,500 years, and is listed in Ben Cao Gang Mu for treating dysentery. In vitro antimicrobial activity against Salmonella typhi and other enteric pathogens provides partial mechanistic support.

Huckleberry leaves and dried berries have a well-documented traditional use as an astringent remedy for diarrhea across Pacific Northwest Indigenous peoples and European herbal traditions. The tannin content is responsible for the astringent action. Germany's health authorities have officially approved the closely related bilberry fruit for mild diarrhea, lending regulatory legitimacy to this application.

Hyacinth bean seed (Bai bian dou) is one of the most historically prominent uses in Traditional Chinese Medicine, where it is prescribed for summer-heat diarrhea and loose stools. Ayurvedic and other traditional systems similarly document use of seeds and stem for cholera and diarrhea. No controlled human trials exist to date.

Boswellia gum resin is explicitly listed in traditional Ayurvedic and Unani texts as a remedy for diarrhoea and dysentery, making this a well-documented traditional indication. Clinical trials in ulcerative colitis show improvements in stool properties. No dedicated RCT in diarrhoea-only patients has been identified.

Acacia nilotica bark and preparations have been used traditionally across Africa and South Asia to treat acute diarrhea. The bark is documented as antidiarrheal in ethnobotanical records, used as a decoction or infusion. Preclinical pharmacological data support antidiarrheal activity via tannin-mediated astringency.

T. cordifolia is consistently documented in Ayurvedic classical texts and ethnomedicinal surveys as a treatment for diarrhea and dysentery. It is listed as 'anti-diarrheal' in multiple pharmacological reviews. No controlled human clinical trial with diarrhea as a primary endpoint has been published.

Indigo leaves are traditionally used in Ayurveda and folk medicine as a treatment for diarrhea, attributed to mild antimicrobial activity against gut pathogens and astringent tannin content. Animal studies on Indigofera species support antidiarrheal properties. No human trials exist for this indication.

Diarrhea is among the earliest and most frequently cited traditional uses of kudzu root in both TCM and classical texts, documented for over 2,000 years. Kudzu root was classically used to treat acute dysentery and diarrhea. Contemporary herbal references continue to list this among its primary indications, though clinical trial evidence specific to diarrhea is lacking.

Lemongrass is documented in folk medicine as an antidiarrheal agent across multiple cultures, attributed to its antispasmodic and antimicrobial properties. Scientific reviews confirm this traditional attribution, though controlled human trials are absent. Its activity against enteric pathogens in vitro lends mechanistic plausibility.

Traditional Chinese and Asian folk medicine documents the use of Syringa species to treat diarrhea, a use cited in multiple peer-reviewed ethnopharmacological reviews. This represents one of the historically most consistent recorded applications of the genus.

In TCM, lotus seeds are among the classic astringent herbs for chronic diarrhea due to spleen deficiency, used for over 2,000 years. Their sweet-astringent nature is held to tonify the spleen and firm the intestines. Dedicated clinical trials for this indication do not exist.

Diarrhea is consistently listed as one of the traditional indications for Adhatoda vasica across Ayurvedic, Unani, and folk ethnobotanical sources. Multiple comprehensive reviews and a ResearchGate pharmacological review confirm anti-diarrheal properties.

Across Ayurvedic, Unani, Caribbean, and African traditional medicine, mango bark, seed kernel, leaves, and unripe fruit are used as antidiarrheal remedies. The astringent tannins in bark and seeds are considered responsible for binding and firming loose stools. These uses are extensively documented in traditional medicine texts.

The pericarp of mangosteen has a centuries-long documented traditional use across Southeast Asia for treating diarrhea and dysentery. Infusions and decoctions of the peel are traditionally prepared for gastrointestinal complaints. Clinical trial evidence is absent, and one animal study suggested possible worsening of colitis.

Marjoram leaf infusion has been used in Ayurvedic and traditional medicine for diarrhea, and marjoram oil is used externally as a hot fomentation for acute diarrhea. Astringent tannins and antimicrobial compounds provide a plausible mechanism.

Marshmallow root has a long traditional use in European and Middle Eastern herbal medicine for diarrhea, attributable to the mucilage coating and soothing the intestinal lining. Traditional herbalists have documented its use for dysentery and enteritis. No human clinical trial evidence exists for diarrhea specifically.

Milkweed root, particularly A. tuberosa, has traditional use for diarrhea and dysentery, attributed to its antispasmodic and astringent properties. Indigenous peoples of North America chewed roots for dysentery. The Eclectic medical tradition also listed pleurisy root for dysentery. No clinical studies have evaluated this application.

Momordica charantia is documented in traditional medicine across Africa, Asia, and Latin America as a remedy for diarrhea and dysentery. An antidiarrheal use appears in multiple ethnopharmacological databases. No human clinical trials have been conducted for this indication.

Mugwort features in medieval European and Asian traditions as a remedy for diarrhea, referenced in the context of gastrointestinal complaints 'resulting from cold.' The antispasmodic and astringent properties of the plant provide pharmacological plausibility. No clinical trials on mugwort for diarrhea exist.

Mullein has been documented as a traditional remedy for diarrhea across multiple cultures, including early American settlers and traditional Turkish medicine. Its astringent tannins are thought to reduce intestinal secretions, while the antispasmodic action relaxes intestinal smooth muscle. No clinical trials in human diarrhea have been conducted.

TC powder has been used in chronic diarrhea across Ayurvedic, Tibetan, Unani, and Siddha medicine based on its astringent properties and activity against intestinal pathogens. Its tannin content reduces intestinal secretions and inhibits key diarrheal pathogens including E. coli and Salmonella.

Neem bark and leaf preparations are used in Ayurveda, Unani, and folk medicine for intestinal dysfunctions including diarrhoea, attributed to its antibacterial activity against enteric pathogens and astringent properties of bark tannins. Clinical trial evidence for diarrhoea specifically is absent.

Nopal is used in traditional medicine in sub-Saharan Africa and Mexico as an antidiarrheal agent. It is listed in traditional pharmacopeias for diarrhea and dysentery. Nopal's fiber content, including mucilage, is biologically plausible for stool normalization. No controlled human trials for diarrhea as a specific endpoint have been identified.

Okra is documented in traditional medicine across Africa, the Middle East, and South Asia for treating dysentery and diarrhea, attributed to its mucilage's soothing and antispasmodic properties. It is also reported to possess anti-adhesive properties against gut pathogens. Clinical trial evidence for this specific indication is absent.

Orange peel has documented traditional use for diarrhoea in Chinese, Ayurvedic, and Western herbal medicine. Tannins and flavonoids in the peel are proposed to have astringent and antimicrobial effects on the gut. Clinical RCT evidence specific to Citrus sinensis for diarrhoea is absent.

Oregano has a long-documented traditional use in treating diarrhea across Mediterranean, Turkish, and Chinese folk medicine systems. The antimicrobial activity of carvacrol and thymol against enteric pathogens such as E. coli and Salmonella provides a plausible mechanism. However, no controlled human clinical trials have specifically evaluated oregano for diarrhea treatment.

P. orientalis has traditional use in Asian medicine for diarrhea and bacillary dysentery. Multiple systematic reviews document this ethnomedicinal application. The plant's tannin content provides a plausible astringent mechanism for reducing intestinal secretion, though no clinical trial data exist.

Papaya seeds and leaves are used traditionally across tropical regions in Asia, Africa, and Latin America to treat diarrhea. The seeds have documented antimicrobial and antiparasitic properties that may underlie this use. Formal controlled human trials for diarrhea as a primary endpoint are lacking.

P. kurroa is documented in Ayurvedic, Tibetan, and Chinese traditional medicine for the treatment of diarrhea and dysentery. This use is consistent across multiple ethnopharmacological sources. There are no human clinical trials specifically evaluating it for this indication.

Pineapple/bromelain has documented traditional use in infectious diarrhea across indigenous Central and South American medicine. Bromelain's antibacterial and anti-inflammatory properties provide mechanistic support, and it has been included in traditional formulas for this condition.

P. umbellatus has a long-standing entry in the Chinese Pharmacopoeia (2010 edition) for the treatment of diarrhea alongside edema. This use is framed in TCM as resolving 'dampness' that settles in the intestines. No dedicated controlled human trials for diarrhea alone have been published.

Pomegranate has been used in Ayurvedic, Chinese, and Middle Eastern traditional medicine for centuries as a treatment for diarrhea and dysentery. The astringent tannins (particularly in the peel) are the proposed active constituents. Robust human clinical trial evidence specifically for diarrhea is limited.

Antidiarrheal use of poppy is one of the oldest and most widely documented traditional applications across Unani, Indian, and Chinese herbal medicine. Opioid alkaloids from P. somniferum reduce intestinal motility via μ-opioid receptors, which is the same mechanism as pharmaceutical loperamide. P. rhoeas is also used traditionally for diarrhea and dysentery.

Antidiarrheal use of prickly pear is documented in sub-Saharan African, Native American, and Latin American traditional medicine. Animal studies show cladode extracts reduced Salmonella typhi load in diarrhea-induced mice. Human clinical trial evidence is absent.

Prunus africana bark is traditionally used for diarrhea in African communities, documented in ethnomedicinal surveys in Kenya and other countries. The tannin content provides an astringent mechanism consistent with antidiarrheal use. Flavonoids in P. africana may suppress intestinal motility and excessive mucus secretion. No clinical trials are available.

P. marsupium gum and bark decoctions have a long-documented history in Ayurvedic and indigenous medicine for the treatment of diarrhea and dysentery. This is attributed to the plant's astringent tannin and kinotannic acid content.

Purslane has been used traditionally across Asia, Africa, and Europe to treat diarrhea and dysentery, reflecting its documented hemostatic, antimicrobial, and astringent properties. No clinical RCTs specifically investigating purslane for diarrhea outcomes in humans were identified in the reviewed literature.

Queen of the meadow has a well-established traditional reputation for treating diarrhea, particularly in children, documented across European herbal traditions and listed in pharmacopeial monographs. The astringent tannin content provides a plausible mechanism for reducing intestinal fluid loss and irritation. No controlled human trials have been conducted.

Radish seed (Raphani Semen, Lai Fu Zi) is listed in the Pharmacopoeia of the People's Republic of China for treating diarrhea and dysentery in combination herbal formulations. This is a formal pharmacopoeial traditional indication. No clinical trials have evaluated radish alone for diarrhea.

Raspberry leaf has a well-documented traditional use for diarrhea across multiple herbal traditions, attributed to its high tannin content, which acts as an astringent on gut mucosa. Native American tribes (Chippewa, Omaha) used raspberry root preparations specifically for dysentery and diarrhea. The German Commission E acknowledged this traditional use, and herbalists such as Tyler cite tannin-rich raspberry leaf as comparable to blackberry for acute non-infectious diarrhea. No controlled human trials have been conducted.

Diarrhea and dysentery are traditional indications for red root documented in Native American ethnobotany, Eclectic materia medica, and Clarke's Dictionary of Practical Materia Medica. The high tannin content (approx. 8–10%) provides a well-established astringent mechanism for reducing intestinal hypersecretion. No clinical trials have been conducted.

Rose hip has documented traditional use for diarrhea, attributed to the astringent tannin content of the fruit, which can reduce intestinal secretion and inflammation. Both RxList and traditional German herbal medicine sources list diarrhea among rose hip's traditional uses. The tannins and pectin provide a dual binding and protective effect on irritated intestinal mucosa.

In traditional Chinese medicine, plant water decoctions of R. cordifolia are used orally to treat diarrhea; external foot baths with the decoction are also used for children. R. cordifolia is a main ingredient in the Chinese traditional formula 'Er-Xie-Ting granule,' used to treat acute infantile diarrhea. One preclinical study noted antidiarrheal and anti-inflammatory activity in rodents.

Sage is documented in folk medicine traditions across Asia, Latin America, and Europe for the treatment of diarrhea, attributed to its astringent tannin content. No dedicated clinical trials in humans evaluating sage specifically for diarrhea could be identified.

In TCM, schisandra is used as an astringent herb to stop diarrhea and 'astringe the jing,' inhibiting excess secretions from the body. Traditional texts (including the Shen Nong Ben Cao Jing) list it for dysentery. A small clinical study in liver transplant patients suggests schisandra may help with diarrhea caused by immunosuppressant medication.

Root preparations of sheep's sorrel have been used in traditional herbal medicine as an astringent remedy for diarrhea. The tannin content of the plant provides a plausible mechanism for this astringent action. No human clinical evidence supports this use.

Shen-chu is traditionally indicated for loose stools and diarrhea arising from food stagnation in TCM. It appears in multi-herb formulas studied for chemotherapy-induced diarrhea and IBS-D, though direct clinical evidence for shen-chu alone in diarrhea is limited to traditional documentation.

Shepherd's purse is consistently documented in European, Russian, and North American folk medicine for chronic diarrhea and dysentery, using its astringent properties to tone intestinal mucous membranes and reduce passive intestinal bleeding. The King's American Dispensatory, Culpeper, and the PMC 2024 review all document this indication.

TCM pharmacopoeias and classical texts document Z. bungeanum (Hua Jiao) as a core remedy for diarrhea, particularly cold-pattern diarrhea. Modern preclinical evidence shows gastrointestinal regulatory effects but human trials for diarrhea specifically are absent.

Classical TCM texts document siler root for abdominal pain and diarrhea attributed to 'wind invading the intestines,' including dysenteric diarrhea with blood. This is among the herb's listed traditional indications. No modern clinical trials for diarrhea as an isolated endpoint have been published.

Diarrhea is consistently listed among the traditional indications for A. julibrissin and related Albizia species in TCM, African, and Indian traditional medicine. Antimicrobial and astringent properties of bark constituents provide a pharmacological rationale.

Native American and historical American herbal traditions document slippery elm as a remedy for diarrhea. Its mucilage and tannins are proposed to soothe the intestinal lining and exert mild astringency. MSKCC explicitly states that evidence is lacking to support this claim in clinical terms.

Slippery elm has been used traditionally by Native Americans for diarrhea, and is cited across herbal references for this indication. The soluble fiber mucilage can absorb excess luminal water and the tannins provide astringent activity. Clinical evidence for slippery elm alone treating diarrhea is lacking; MSKCC states evidence is absent for this specific claim.

Diarrhea is one of the most consistently documented traditional uses of smartweed across Unani, Ayurveda, Siddha, Chinese, and European folk medicine. The plant's astringent properties (tannins) and its role as a stomachic are the traditional rationale. No human clinical trials confirming efficacy exist.

Solomon's seal is documented in multiple herbal traditions as an antidiarrheal, working via astringent toning of the intestinal mucosa to reduce excessive bowel movement frequency. The White Rabbit Institute and Drugs.com both list diarrhea among its medicinal applications.

S. flavescens (Ku Shen) has a documented traditional use for diarrhea and dysentery in Chinese medicine, recorded in the Compendium of Materia Medica from the Ming dynasty. Alkaloids with antimicrobial and anti-inflammatory intestinal activity provide a plausible mechanism.

Spearmint has been used in traditional Iranian medicine for diarrhea management, and is listed among traditional plant medicines for intestinal complaints in multiple ethnopharmacological reviews. No clinical trials in humans test this specific endpoint.

Squawvine was used by the Cherokee people for dysentery and diarrhea, documented in ethnobotanical records. Its tannin-rich phytochemical profile provides a mechanistic rationale for astringent anti-diarrheal activity. Multiple traditional herbal sources confirm this use.

Sweet wormwood was traditionally used in Asian medicine to treat bacterial dysentery and diarrhea. This use is documented in traditional Chinese medicine (TCM) sources. Modern clinical evidence specific to diarrhea as a primary endpoint is absent.

T. chebula (haritaki) has extensive, well-documented traditional use for diarrhea and dysentery across Ayurvedic, Unani, Siddha, and Traditional Chinese Medicine systems. Ripe fruits are used as astringents to control loose stools. Pharmacological data support antidiarrheal mechanisms through astringent tannins and antimicrobial activity, but robust human RCTs for this specific indication are limited.

Wild thyme (Thymus serpyllum) has been traditionally used in Europe and North Africa to treat diarrhea, documented in ethnopharmacological literature and acknowledged in PMC pharmacological reviews. The tannin content of thyme provides astringent action on the intestinal mucosa. Preclinical data support intestinal anti-inflammatory properties relevant to diarrheal pathology.

Thymus vulgaris has traditional documented use for diarrhea in herbal medicine, attributed to its antispasmodic and antimicrobial properties. The PMC-indexed literature notes T. vulgaris has traditionally been administered for gastritis and gastrointestinal complaints including diarrhea. No dedicated clinical trials for diarrhea have been published.

Terminalia chebula (Haritaki), a key Triphala component, has documented astringent properties used traditionally for diarrhea management in Ayurveda and other traditional systems. The tannin-rich profile of Triphala supports its antidiarrheal application. Human clinical evidence specific to diarrhea endpoints is limited.

Tylophora has a documented history of traditional use in India, Bangladesh, and Sri Lanka for diarrhea and dysentery, and is cited in multiple ethnopharmacological reviews as an antidiarrheal plant. Pharmacological in vitro and in vivo studies have attributed antidiarrheal activity to Tylophora extracts, supporting the traditional claim at a preclinical level.

Wheatgrass is documented in traditional naturopathic medicine as a remedy for diarrhea, appearing alongside constipation in historical use records. No clinical trial has evaluated this specific claim. The anti-inflammatory and antimicrobial properties of chlorophyll provide mechanistic context.

White oak bark has a long history of use for acute diarrhea, supported by Germany's Commission E approval and mechanistic plausibility via tannin astringency. The ellagitannins in the bark inhibit intestinal secretion, reducing fluid loss. However, no controlled clinical trials in humans have been completed specifically on white oak bark for this indication.

Wood betony is documented in folk and traditional herbal medicine for diarrhea, justified by its high tannin content providing astringent action on the intestinal mucosa. This is among its most consistently recorded traditional uses.

Diarrhea is listed as a traditional indication for X. strumarium across Pakistani, Bangladeshi, Indian, and Chinese ethnomedicinal traditions. This seemingly contradictory pairing with its laxative properties reflects its traditional role as a gastrointestinal regulator in folk medicine. No pharmacological diarrhea-model studies have been identified.

Yarrow has a long tradition of use for diarrhea and dysentery across Persian, Iranian, North American indigenous, and European folk medicine, attributed to its astringent tannin content and antimicrobial essential oil. No clinical trials specifically on diarrhea have been published.

Zanthoxylum species have a long-documented tradition in Chinese, African, and South Asian medicine for treating diarrhea and intestinal disorders. The 2020 Chinese Pharmacopoeia lists Z. bungeanum, Z. schinifolium, and Z. nitidum in part for digestive complaints including diarrhea. Mechanistic antispasmodic and antimicrobial preclinical data support this use, but no dedicated human trials exist.